Cargando…
Cost effectiveness of the cancer prevention program for carriers of the BRCA1/2 mutation
OBJECTIVE: To analyze the cost effectiveness of the diagnostic program for the germline mutation in BRCA1/2 genes and of preventative strategies for the relatives of patients diagnosed with ovarian cancer associated with this mutation. METHODS: The study analyzed the cost effectiveness by developing...
Autores principales: | Ramos, Marcelo Cristiano de Azevedo, Folgueira, Maria Aparecida Azevedo Koike, Maistro, Simone, Campolina, Alessandro Gonçalves, de Soárez, Patricia Coelho, de Bock, Geertruida Hendrika, Novaes, Hillegonda Maria Dutilh, Diz, Maria Del Pilar Estevez |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculdade de Saúde Pública da Universidade de São Paulo
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280621/ https://www.ncbi.nlm.nih.gov/pubmed/30517521 http://dx.doi.org/10.11606/S1518-8787.2018052000643 |
Ejemplares similares
-
Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil
por: Maistro, Simone, et al.
Publicado: (2016) -
How Should Genetic Counseling for Ovarian Cancer Be Implemented in a Middle-Income Country? An Insight Based on the Brazilian Scenario
por: Koike Folgueira, Maria Aparecida Azevedo, et al.
Publicado: (2018) -
Challenges to decision-making processes in the national HTA agency in Brazil: operational procedures, evidence use and recommendations
por: Yuba, Tania Yuka, et al.
Publicado: (2018) -
Multiple Criteria Decision Analysis (MCDA) for evaluating cancer treatments in hospital-based health technology assessment: The Paraconsistent Value Framework
por: Campolina, Alessandro Gonçalves, et al.
Publicado: (2022) -
Integrated care pathway for rectal cancer treatment: cross-sectional post-implementation study using a logic model framework
por: Kobayashi, Silvia Takanohashi, et al.
Publicado: (2020)